CMRA (CMRA) Stock Price & Analysis
CMRA (CMRA) rose 0.00% to USD 0 as of June 10, 2026 at 02:18 UTC, according to Nexqual real-time market data.
CMRA last closed at USD 0; the session ranged USD 0–0 on volume of 730 shares. Market capitalization is $3,073, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, June 10, 2026 at 02:18 UTC.
Key Statistics (as of June 10, 2026 at 02:18 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 730 shares |
| Market Cap | $3,073 |
| Exchange | PNK |
Technical Analysis (CMRA)
Nexqual's technical model rates CMRA "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 02:18 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (CMRA)
Wall Street analysts rate CMRA "None", per Nexqual as of June 10, 2026 at 02:18 UTC.
| Consensus Rating | None |
|---|
Earnings (CMRA)
Source: Nexqual, June 10, 2026 at 02:18 UTC.
Financials & Fundamentals (CMRA)
| Total Revenue | $1.00M |
|---|---|
| Revenue Growth (YoY) | -42.00% |
| Gross Margin | +73.52% |
| Operating Margin | -1582.47% |
| Profit Margin | +0.00% |
| ROE | -1629.02% |
| Debt / Equity | 549.04 |
| Current Ratio | 0.9 |
| Total Cash | $1.77M |
| Total Debt | $561,468 |
| Free Cash Flow | $-2.99M |
Source: Nexqual, June 10, 2026 at 02:18 UTC.
Financial Health Score (CMRA)
Nexqual rates CMRA's overall financial health "Critical" across five dimensions, as of June 10, 2026 at 02:18 UTC.
| Growth | Critical — Revenue -42% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Critical — $2M cash, no debt |
| Cash Flow | Weak — FCF negative: -$3M, burning cash |
| Efficiency | Critical — ROE -1629%, ROA -119.3% |
Ownership (CMRA)
| Insider Ownership | +62.18% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 30.74M |
| Float | 13.53M |
| Short % of Float | +1.36% |
Source: Nexqual, June 10, 2026 at 02:18 UTC.
Leadership (CMRA)
CMRA is led by Michael G. Campbell (age 57), CEO, CFO & Principal Accounting Officer, per Nexqual as of June 10, 2026 at 02:18 UTC.
| CEO, CFO & Principal Accounting Officer | Michael G. Campbell (age 57) |
|---|
Major Backers & Investors (CMRA)
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 0.28% |
Source: Nexqual, June 10, 2026 at 02:18 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PXMD | PaxMedica, Inc. | USD 0 | ▲ 0% |
| ILAG | Intelligent Living Application | USD 3.73 | ▲ 6.57% |
| HPCO | Hempacco Co., Inc. | USD 0 | ▲ 0% |
| IONM | Assure Holdings Corp. | USD 0 | ▲ 0% |
| BTTX | Better Therapeutics, Inc. | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 02:18 UTC. This page is informational and not investment advice.